AIDGenomics
AID Genomics is a research and development-driven diagnostic company focused on precision medicine, primarily for oncology, but also for hereditary rare diseases and infectious diseases. Their mission is to make genomic medicine accessible and affordable, improving patient care and quality of life. The company utilizes cutting-edge technologies like next-generation sequencing (NGS), miRNA, and epigenetics, combined with AI-based analytical tools. AID Genomics aims to enable early cancer detection, provide advanced AI analytics for diagnostics, and develop innovative genomic tests. They are particularly focused on early cancer detection technologies, automation solutions for laboratory workflows, and NGS-based cancer therapy selection solutions. The company also plays a role in fighting infectious diseases, notably by providing COVID-19 testing and related services. AID Genomics has established laboratories in Israel and has expanded its services internationally, focusing on comprehensive sequencing of tissue and liquid biopsies.
AIDGenomics
AID Genomics is a research and development-driven diagnostic company focused on precision medicine, primarily for oncology, but also for hereditary rare diseases and infectious diseases. Their mission is to make genomic medicine accessible and affordable, improving patient care and quality of life. The company utilizes cutting-edge technologies like next-generation sequencing (NGS), miRNA, and epigenetics, combined with AI-based analytical tools. AID Genomics aims to enable early cancer detection, provide advanced AI analytics for diagnostics, and develop innovative genomic tests. They are particularly focused on early cancer detection technologies, automation solutions for laboratory workflows, and NGS-based cancer therapy selection solutions. The company also plays a role in fighting infectious diseases, notably by providing COVID-19 testing and related services. AID Genomics has established laboratories in Israel and has expanded its services internationally, focusing on comprehensive sequencing of tissue and liquid biopsies.